Literature DB >> 23688054

Prognostic values of VEGF and IL-8 in malignant pleural effusion in patients with lung cancer.

Daye Cheng1, Hong Kong, Yunhui Li.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the prognostic value of VEGF and IL-8 in pleural effusion in patients with lung cancer. MATERIALS AND
METHOD: Commercially available ELISA was used to determine VEGF and IL-8 levels.
RESULTS: The level of VEGF showed significant correlations with lymph node metastasis and distant metastasis. But, IL-8 was only correlated with lymph node metastasis. Univariate and multivariate analysis revealed elevated VEGF level was an independent predictor of shorter OS and DFS.
CONCLUSION: VEGF could be an important component that contributes to pleural effusion formation, and an important prognostic factor for lung cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688054     DOI: 10.3109/1354750X.2013.797499

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  8 in total

1.  Lung cancer cells induce senescence and apoptosis of pleural mesothelial cells via transforming growth factor-beta1.

Authors:  Zhi-Feng Miao; Wen-Ya Li; Zhen-Ning Wang; Ting-Ting Zhao; Ying-Ying Xu; Yong-Xi Song; Jin-Yu Huang; Hui-Mian Xu
Journal:  Tumour Biol       Date:  2014-11-30

2.  Vascular endothelial growth factor and protein level in pleural effusion for differentiating malignant from benign pleural effusion.

Authors:  Da-Wei Wu; Wei-An Chang; Kuan-Ting Liu; Meng-Chi Yen; Po-Lin Kuo
Journal:  Oncol Lett       Date:  2017-07-20       Impact factor: 2.967

Review 3.  Closing faucets: the role of anti-angiogenic therapies in malignant pleural diseases.

Authors:  D Marquez-Medina; S Popat
Journal:  Clin Transl Oncol       Date:  2015-12-17       Impact factor: 3.405

4.  The -1154 G/A VEGF gene polymorphism is associated with the incidence of basal cell carcinoma in patients from northern Poland.

Authors:  Michał Sobjanek; Monika Zabłotna; Aleksandra Lesiak; Igor Michajłowski; Aneta Szczerkowska-Dobosz; Małgorzata Sokolowska-Wojdylo; Roman Nowicki
Journal:  Arch Dermatol Res       Date:  2014-06-06       Impact factor: 3.017

5.  Differential diagnosis of lung cancer, its metastasis and chronic obstructive pulmonary disease based on serum Vegf, Il-8 and MMP-9.

Authors:  Murali M S Balla; Sejal Desai; Pallavi Purwar; Amit Kumar; Prashant Bhandarkar; Yogesh K Shejul; C S Pramesh; S Laskar; Badri N Pandey
Journal:  Sci Rep       Date:  2016-11-04       Impact factor: 4.379

6.  Prognosis of EGFR-mutant advanced lung adenocarcinoma patients with different intrathoracic metastatic patterns.

Authors:  Fang Hu; Bo Zhang; Changhui Li; Jianlin Xu; Huimin Wang; Ping Gu; Xiaoxuan Zheng; Wei Nie; Yinchen Shen; Hai Zhang; Ping Hu; Xueyan Zhang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

7.  Identification of differentially expressed miRNAs in differentiating benign from malignant pleural effusion.

Authors:  Quanlei Bao; Yaping Xu; Ming Ding; Ping Chen
Journal:  Hereditas       Date:  2020-02-26       Impact factor: 3.271

8.  Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer.

Authors:  Hui Xiao; Juan Wang; Yanan Liu; Li Li
Journal:  Oncol Lett       Date:  2014-05-23       Impact factor: 2.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.